SCHEMBL3784766

SCHEMBL3784766

CCOC(=O)N(C(=O)OCC)c1cc2cc-2c1.OBO

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
CTDSP1 Q9GZU7 1/20 0.36
LMNA P02545 3/20 0.35
CA12 O43570 1/20 0.34
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
CA7 P43166 1/20 0.34
CA9 Q16790 1/20 0.34
CA14 Q9ULX7 1/20 0.34
SMN1; SMN2 Q16637 3/20 0.34
ALDH1A1 P00352 5/20 0.33
HSD17B10 Q99714 2/20 0.33
MAPT P10636 2/20 0.33
HPGD P15428 2/20 0.33
CYP1A2 P05177 2/20 0.33
CYP2C9 P11712 2/20 0.33
CYP2C19 P33261 2/20 0.33
NR1H2 P55055 1/20 0.33
NR1H3 Q13133 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3787025 0.79
SCHEMBL3781111 0.79 ALDH1A1 (0.49) MEN1KMT2ACTDSP1LMNASMN1; SMN2
SCHEMBL3790807 0.76 ALDH1A1 (0.45) KMT2ALMNAALDH1A1MAPTHPGD
SCHEMBL3789282 0.75 BRD4 (0.35)
SCHEMBL3783532 0.73 KMT2A (0.34) MEN1KMT2ACTDSP1LMNACA12
SCHEMBL11400006 0.72 RAB9A (0.49) MEN1KMT2ACTDSP1LMNASMN1; SMN2
SCHEMBL1533658 0.69 CTDSP1 (0.40) MEN1KMT2ACTDSP1LMNACA12
SCHEMBL1518831 0.68 LMNA (0.43) CTDSP1LMNASMN1; SMN2ALDH1A1HSD17B10
SCHEMBL10869589 0.67 ALDH1A1 (0.48) MEN1KMT2ACTDSP1LMNASMN1; SMN2
SCHEMBL5933087 0.66 ALDH1A1 (0.51) MEN1KMT2ACTDSP1LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 US disclosed
EP-1914221-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-04-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND NISCH, BLVRB, BBOX1 MEN1 174/4885KMT2A 1474/4885CTDSP1 4664/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.